A Retrospective Analysis of Autologous Peripheral Blood Hematopoietic Stem Cell Mobilizations and Collections in 109 Multiple Myeloma Patients

Yun XU,Cheng-cheng FU,Juan WANG,Jin ZHOU,Ying YAO,Wei-qin YAO,Ling-zhi YAN,Jing-jing SHANG,Song JIN,Fei-ran GONG,Jia-zi ZHOU,Zi-ling ZHU,Hui-rong CHANG,Ming-qing ZHU,Xia-ming ZHU,Ai-ning SUN,De-pei WU
DOI: https://doi.org/10.3969/j.issn.1009-881X.2017.01.009
2017-01-01
Abstract:Objective To compare the collection efficiency and safety of the two regiments of mobilization:cyclophosphamide (CTX) combined with G-CSF and G-CSF alone. Methods Retrospective analysis of peripheral blood stem cell collection data of 109 multiple myeloma patients who were treated with CTX combined with G-CSF or G-CSF alone mobilization from April 2004 to June 2015. The collection efficiency and adverse reactions were compared between the two groups. Results 109 cases of patients have carried out 118 cases of mobilization of hematopoietic stem cell collection. In the 109 cases, successful mobilization rate and good mobilization rate were respectively 85.3% and 27.5%, the median CD34+ cells harvested was 3.44 (1.14~14.23)×106/kg. The successful mobilization rate of CTX + G-CSF group and G-CSF group were respectively 87.0% and 81.2%(P=0.633). The good mobilization rate of CTX + G-CSF group and G-CSF group were respectively 35.1% and 9.4% (P=0.006). The median of CD34+ cells obtained from CTX + G-CSF and G-CSF groups were respectively 3.69 (1.14~14.23)×106/kg and 2.79 (1.34~6.49)×106/kg (P=0.332). In terms of adverse reactions, the incidence of leukopenia grade 3 or worse in CTX + G-CSF group and G-CSF group was 57.1% and 21.9%(P=0.001).The incidence of leukopenia grade 3 or worse in CTX + G-CSF group and G-CSF group was 51.9%and 25.0% (P=0.010). Conclusion For patients with multiple myeloma, there was no difference in the success rate of CTX combined with G-CSF and G-CSF mobilization regimens, while the former was superior to the latter in good mobilization rate. In terms of safety, the two groups of mobilization programs are equivalent. Therefore, mobilization of CTX + G-CSF is superior to G-CSF alone in peripheral blood stem cell collection in patients with multiple myeloma.
What problem does this paper attempt to address?